Clinical Trial

Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A Controlled Human Infection Model (CHIM) is being developed to provide early proof-of-concept that experimental infection with the intestinal nematode, Trichuris trichiura, is feasible and safe. The proposed model consists of enrolling consenting, healthy, trichuriasis-naïve adults and challenging them with the investigational product, Trichuris trichiura Egg Inoculum, to assess their ability to result in detectable infection. The proposed study will be a feasibility study that will consist of administering different doses of the Trichuris trichiura Egg Inoculum to healthy adult volunteers to determine the optimal dose (i.e., number of T. trichiura eggs) that is safe, well-tolerated and results in consistent infection.
Trial Details
NCT Number NCT05706116
Lead Sponsor George Washington University
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions Whipworm, Trichuriasis, Controlled Human Infection
Enrollment 18 participants
Start Date 2025-09-10
Primary Completion 2027-10-23 (estimated)
Study Completion 2028-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-04